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A previously healthy 74-year-old Caucasianman with penicillin allergy was admitted with evolving headache, confusion, fever, and
neck stiffness. Treatment for bacterial meningitis with dexamethasone andmonotherapy ceftriaxone was started.The cerebrospinal
fluid showed negative microscopy for bacteria, no bacterial growth, and negative polymerase chain reaction for bacterial DNA.The
patient developed hydrocephalus on a secondCT scan of the brain on the 5th day of admission. An external ventricular catheter was
inserted and Listeria monocytogenes grew in the cerebrospinal fluid from the catheter.The patient had severe neurological sequelae.
This case report emphasises the importance of covering empirically for Listeria monocytogenes in all patients with penicillin allergy
with suspected bacterial meningitis. The case also shows that it is possible to have significant infection and inflammation even
with negative microscopy, negative cultures, and negative broad range polymerase chain reaction in cases of Listeria meningitis.
Follow-up spinal taps can be necessary to detect the presence of Listeria monocytogenes.
1. Introduction
Listeriamonocytogenes(LM)meningitis isararedisease entitywith
an estimated incidence of 0.03–0.2 cases/100.000 people/year
[1, 2]. The disease is mainly transmitted by contaminated
food and has been associated with newborn infants, pregnant
women, and patients with comorbidity, to elderly and to
immunosuppressed individuals [3–6]. Listeriameningitis can
be difficult to diagnose because of no optimal sensitivities
in diagnostic tests of the cerebrospinal fluid (CSF) and
blood cultures [7, 8]. The patient reported in this case
report illustrates very well the clinical dilemmas in this
serious condition, where even modern laboratory analyses
showed failing sensitivities in a patient with penicillin allergy,
not covered for Listeria infection up-front at the time of
admission.
2. Case Presentation
A 74-year-old Caucasian immunocompetentmanwas admit-
ted with an anamnesis of just 24 hours with evolving
headache, fever, and confusion. The patient was known
for having an uncomplicated essential hypertension treated
with amlodipine; epilepsy treated with lamotrigine and no
convulsions for many years; no previous hospital admissions.
He was fit and physically active as a hobby farmer and as an
active mountain walker. At the time of admission he had a
GlasgowComa Scale (GCS) score of 14 points, temperature of
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40 degrees Celsius, normal vital parameters, petechia on both
legs, and neck stiffness. He had no focal neurological deficits
and no convulsions. Blood chemistry showed leukocytes
of 14.1 × 109/L, neutrophils of 12.2 × 109/L, creatinine of
119micromol/L, INR of 1.2, blood glucose of 7.7mmol/L,
and a C-reactive protein (CRP) of 131mg/L (reference value:
<3mg/L). A spinal tap showed turbid CSF with pleocytosis of
1877 × 106/L, 78% of neutrophils, CSF protein of 1.9 g/L, CSF
glucose of 3.7mmol/L, and CSF lactate of 5.2mmol/L (refer-
ence value: 0.9–2.8micromol/L). Gram staining of the CSF
was negative for bacteria. After the spinal tap the patient was
started promptly on treatment with intravenous dexametha-
sone 10mg four times a day for 4 days and with intravenous
ceftriaxone 4 g once daily, according to our guidelines in 2011
for empirical treatment of bacterial meningitis in patients
with penicillin allergy. According to our guidelines patients
without penicillin allergy should be treatedwith combination
antibiotic treatment of ceftriaxone and benzylpenicillin or
ampicillin (as coverage for possible Listeria meningitis).
During the first day of admission the GCS score fell to under
12 points and aCTof the brainwas performedwith no signs of
hydrocephalus or other complications to bacterial meningitis
(Figure 1). Because neither the CSF nor the blood cultures
showed any growth on the second day of admission, CSF was
sent to the National Reference Laboratory ofMicrobiology in
Copenhagen, Denmark (Statens Serum Institut), for exten-
sive polymerase chain reaction (PCR) analyses for bacterial
and viral pathogens. These PCR examinations of the CSF
from the day of admission were negative for herpes simplex
virus, varicella zoster virus, Cytomegalovirus, Epstein-Barr
virus, Enterovirus, and Mycoplasma pneumoniae, specific
PCR for Streptococcus pneumoniae, specific PCR forNeisseria
meningitidis, and a broad range 16sRNA PCR for bacterial
DNA. A urine sample was also negative for pneumococcal
urine antigen. At the same time treatment was intensified
with intravenous aciclovir 750mg three times a day. On
the third and fourth day of admission the patient seemed
to improve a little bit clinically, with rising GCS score to
14, falling levels of CRP, but still with temperature over
40 degrees Celsius despite maximum dose of antipyretic
paracetamol (4 g/day). On the fifth day of admission his
clinical state deteriorated with falling GCS score under 10
and eye deviation to the left side but otherwise without
neurological deficits. A new CT of the brain on the fifth day
of admission now showed development of a communicating
hydrocephalus (Figure 2). The patient was changed from
ceftriaxone to intravenous meropenem 2 g three times daily
on the indication of clinical failure on ceftriaxone treatment.
Thepatientwas transferredwith ambulance airplane from the
Faroe Islands to Copenhagen, Denmark, where an external
ventricular catheter was inserted the same evening. CSF from
this catheter showed fast growth of LM with normal resis-
tance patterns and as expected resistance to cephalosporins.
The Listeria strain was typed at the Faroese Food Security
Agency as LM serotype 1/2a. After the identification of LM
in the CSF, aciclovir was discontinued, and the patient was
treated with meropenem for 6 weeks. A small brain abscess
formation in relation to the external ventricular catheter was
Figure 1: CT of the brain with intravenous contrast on the first day
of admission showing no intracranial pathology, no hydrocephalus,
and no brain abscess formation.
Figure 2: CT of the brain without intravenous contrast on the
fifth day of admission showing development of a communicating
hydrocephalus.
the reason for the long meropenem treatment. This small
brain abscess formation was interpreted as a complication
to the external ventricular catheter treatment. The patient
was treated at the intensive care unit (ICU) for 5 weeks,
four of these weeks on ventilator. During the stay at the
ICU the patient had to have inserted external ventricular
catheter three times. When the antibiotic treatment finished,
the patient had severe neurological sequelaewith tetraparesis,
convulsions, and very low cognitive functions. A control CT
of the brain 7months after admission showed severe sequelae
in the brain structure (Figure 3). The patient was admitted
to a normal medical ward for one whole year, before being
sent to a nursing home, but died shortly after. There was no
indication of how the patient was infected with LM and no
food investigation was done relating to this case.
Case Reports in Neurological Medicine 3
Figure 3: CT of the brain with intravenous contrast 6 months after
admission showing progression of hydrocephalus.
3. Discussion
LM meningitis is a very serious disease with an estimated
case fatality rate of 17–24% [6, 8]. Data indicate a rise in the
incidence of severe infections with LM [1, 2]. LM infections
have previously been associated with the extreme of ages,
involving newborns and the elderly, and also associated with
significant comorbidity, immunosuppression, and pregnancy
[3–5]. Up to 30–40% of LMmeningitis cases are occurring in
immunocompetent elderly patients [2].
From the literature it is known that only approx. 10–30%
of Gram stains of CSF are positive in LM meningitis [7].
Cultures of the CSF do not have an optimal sensitivity with
positive cultures in 83% of patients with LM meningitis [8].
Finally blood cultures are positive in only 46–64% of LM
meningitis patients [6, 8]. However inmost cases one ormore
of the diagnostic modalities (CSF Gram stain, CSF culture,
and blood cultures) are positive for LM. Reports have also
been on patients diagnosed with molecular methods in the
form of PCR, identifying DNA from LM meningitis [3, 9].
The literature has previously reported the need of reevalua-
tion with follow-up spinal tap of initially microscopy/culture
negative patients [10]. Follow-up spinal taps have previously
identified LMmeningitis like in our case [10].
Hydrocephalus is a known potential complication of
bacterial meningitis in approx. 5% of cases and has been
associated with LM meningitis [6, 8, 11]. The occurrence of
hydrocephalus in LM meningitis cases has been reported to
be 14-15% [6–8]. The prognosis of hydrocephalus patients
with LM is poor and showed an unfavourable outcome in
100% of patients in a Dutch study with LM meningitis and
hydrocephalus [11]. In this study all four patients with the
combination of hydrocephalus and meningitis, treated with
external ventricular catheter, had a poor outcome, with three
fatal cases and one with severe neurological sequelae [11].
A Spanish observational study on LM meningitis showed
that the combination of LM meningitis and hydrocephalus
had a poor outcome with a mortality of 43% of the patients
[8]. In the same study the mortality rate in patients with
LM meningitis and hydrocephalus treated with external
ventricular catheter was 29% [8].
Third-generation cephalosporins are the backbone of
empirical treatment of bacterial meningitis, until the treat-
ment can be adjusted to the identified pathogen and the resis-
tance pattern [12]. Third-generation cephalosporins cover
the most common pathogens, Streptococcus pneumoniae and
Neisseria meningitides, but also other streptococci, MSSA
Staphylococcus aureus and enterobacteria [12]. In countries
with high level of cephalosporin-resistant pneumococci,
MRSA Staphylococcus aureus, or/and ESBL enterobacteria,
vancomycin or/and meropenem can be needed in empirical
regimes for bacterial meningitis [12]. LM is an important
exception and resistant to cephalosporins [12]. Therefore it
is common in empirical antibiotic regimes to cover for the
possibility of LM with the addition of ampicillin or amoxi-
cillin to the treatment with a third-generation cephalosporin
[12]. In Scandinavia benzylpenicillin is often used to cover
for Listeria monocytogenes, as add-on drug to the backbone
treatment with a third-generation cephalosporin [13]. Our
guidelines did not cover for LM meningitis in cases with
penicillin allergy in 2011, when our case occurred. In the
new national Danish guidelines for bacterial meningitis,
meropenem is recommended for patients with penicillin
allergy [14]. The experience in using meropenem in LM is
limited, but data suggest it can be used [15, 16]. Sulfamethox-
azole/trimethoprim has for a longer time been used as an
alternative non-beta-lactam antibiotic to ampicillin, amoxi-
cillin, or benzylpenicillin, in patients with penicillin allergy
[12]. In many countries gentamicin is added to ampicillin,
amoxicillin, or benzylpenicillin to have a synergistic effect in
culture proven infection with LM [12]. However studies have
also indicated that the use of gentamicin in LM meningitis
could increase kidney damage and mortality, so the role of
gentamicin in LM meningitis is pending [17]. The patient in
this case report was not covered for LM for 4 days, before
being switched over from ceftriaxone to meropenem. The
clinical improvement the first two days, with falling CRP,may
be related to the four-day treatment with dexamethasone.
Most cases of LMmeningitis will be positive in one ormore of
the following diagnostic test methods/samples within 24–48
hours: CSF Gram stain, CSF cultures, or the blood cultures.
A positive early test for LM in our case would have guided
our clinicians in an earlier stage towards the diagnosis of LM
and a relevant antibiotic change could have been done. The
combination of penicillin allergy and therefore avoidance of
benzylpenicillin (or ampicillin or amoxicillin) covering for
LM up-front in our patient, combined with negative CSF
Gram stain, negative CSF cultures, negative blood cultures,
and negative CSF broad range PCR for bacterial DNA, was
very unfortunate. Our patient demonstrates the weaknesses
of evenmodern sensitivemolecularmethods like broad range
PCR indiagnosing LMmeningitis. Even if our patient showed
significant clinical and biochemical inflammation of the
central nervous system up-front at admission, LM could not
be detected in the CSF sample taken before administration
of antibiotics. It is possible that the inoculum of LM in our
patient was extremely small and therefore undetectable in
microscopy, in culturing of the CSF, in blood cultures, and
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in our broad range 16sRNA PCR for bacterial DNA. Still
this possibly small inoculum seemed to provoke a significant
inflammatory and clinical response with significant clinical
symptoms and clinical findings lasting only 24 hours before
admission andwith negative culture of the first spinal tap. It is
possible that the potent dexamethasone immunosuppressive
treatment for four days, following standard protocol for
bacterial meningitis, optimised conditions for growth of
LM in the CSF over the next 5 days. On top of this, the
patient developed hydrocephalus during the first 5 days after
admission, resulting in a long stay at the ICU, intubated
in ventilator with insertion of external ventricular catheters
three times by the neurosurgeons. Clinically and documented
with CT of the brain, 7 months after the admission he had
severe neurological sequelae and tetraparesis.
A rare and severe manifestation of neuroinfection with
LM is rhombencephalitis (RE), involving the brain stem and
the cerebellum, normally visualised with MRI of the brain
[18]. No MRI of the brain was performed in our case, and
therefore we cannot exclude a possible presence of RE in
our patient. LM RE usually follows a biphasic time course,
with first a flu-like prodrome in up to 15 days, before severe
meningitis and/or encephalitis symptoms occur, resulting in
acute hospital admission [18]. LM RE occurs in younger
patients than classical LMmeningitis/encephalitis and occurs
also in immunocompetent patients [18]. Unilateral cranial
nerve deficits are almost always present in LM RE [18]. The
patient described in this case report was elderly, although
immunocompetent. He had no anamnesis of a flu-like pro-
drome before his admission and he had no cranial nerve
deficits. His symptoms and his anamnesis were therefore not
typical of LM RE, but no MRI of the brain was performed in
the acute phase of his LMmeningitis, and thereforewe cannot
rule out LM RE definitely.
In conclusion we present a patient with up-front culture
negative LM meningitis, combined with the presence of
penicillin allergy, and therefore lacking antibiotic coverage
for LM the first 4 days of admission. The patient developed
hydrocephalus and severe neurological sequelae and died
after one year. This case report emphasises the importance
of antibiotic coverage for LM in all patients with suspected
bacterial meningitis, including those with penicillin allergy.
It also emphasises the need to reevaluate the diagnosis with
follow-up spinal taps to detect possible evolving LM infection
in patients with suspected bacterial meningitis and lacking
clinical response on the empirical treatment and at the
same time microscopy/culture negative CSF, culture negative
blood, and negative broad range 16sRNA examinations for
bacterial DNA.
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